Understanding China's healthcare market and its evolutions

The Chinese healthcare market is experiencing an unprecedented growth that is presenting burgeoning opportunities for Flemish companies. China is now the second largest market in the world for medical devices and pharmaceuticals.

China's healthcare service market is also quickly becoming one of the largest in the world. Healthcare reform has become one of the priorities of the Chinese government. It is expected that the industry will grow from RMB 6 trillion to RMB 17 trillion between 2020 and 2030. This sharp rise derives from an ageing population coupled with an increasingly affluent population.

Taking into account these opportunities, the Flanders-China Chamber of Commerce will organise a 6-module course focused on helping companies to enter the Chinese market. This project is aimed at innovative companies in the pharma, biotech, medtech, medical insurance and nutrition sectors.

The programme will give participants a better understanding of the general Chinese healthcare market. Business executives will learn about the general healthcare landscape and how it has evolved, as well as the opportunities and the challenges, best practices and lessons learned, negotiation tactics, legislation, product registration, financial incentives, production and sales.

The series of webinars will end with a matchmaking meeting, where participants will have the opportunity to introduce themselves to potential Chinese partners and investors.

Gwenn Sonck

Moderator, Executive Director, FLANDERS-CHINA CHAMBER OF COMMERCE

Franck Le Deu

Senior Partner, MCKINSEY GREATER CHINA

Bart Boschmans

Flemish Trade Commissioner in Shanghai, China, FLANDERS INVESTMENT & TRADE